AZN) shares tanked in the after-hours session Tuesday, as the British drugmaker said it has temporarily halted the advanced trials of its COVID-19 vaccine to allow for a review of safety data by an independent committee.
according to Reuters.The British drugmaker reportedly said it is working so that the review can be carried out expeditiously without impacting the trial’s timeline.” data-reactid=”20″>What Happened: The company said the stopping of the trial was a routine action after any participant develops an unexplained illness, according to Reuters.The British drugmaker reportedly said it is working so that the review can be carried out expeditiously without impacting the trial’s timeline.
report.” data-reactid=”21″>The Phase 3 study of the vaccine was suspended after a serious adverse reaction in a participant in the United Kingdom, according to a Stat report.
A person familiar with the matter told the publication that the suspension would have an impact on other AstraZeneca trials underway as well as affect vaccine trials being conducted by various manufacturers.
reported separately. ” data-reactid=”28″>Brazil’s health regulator Anvisa said Tuesday that the company has informed it of trial suspension, including the one underway in the country, Reuters reported separately.
BNTX), Pfizer Inc (NYSE: PFE), Moderna Inc (NASDAQ: MRNA), Johnson & Johnson (NYSE: JNJ), and GlaxoSmithKline Plc (NYSE: GSK).
The Centers for Disease Control and Prevention had notified all 50 states last week to begin preparations for distributing two unnamed vaccines thought to be those from Pfizer and Moderna.
The guidelines from the agency came the same day President Donald Trump said a vaccine could be ready before the end of the year.
View Article Origin Here
